January 10, 2025 Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers read more
CTAD 2024 Quanterix Fireside Chat with Henrik Zetterburg: Advances in Blood-Based Biomarkers for Alzheimer’s Disease read more
May 17, 2024 Q&A: Blood-based biomarker testing ‘scientific consensus favorite’ for AD detection read more
January 26, 2024 Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer’s Disease Pathology read more
October 3, 2023 Ultrasensitive immunoassay technology drives blood-based biomarkers for Alzheimer’s disease read more
February 14, 2025 2024 Year In Review by Dr. Laia Montoliu-Gaya: Key Findings in Blood Based Biomarkers for Alzheimer’s Disease read more
February 12, 2025 Key Takeaways from Quanterix’s Webinar: From Compliance to Success: Navigating EU IVDR for Clinical Studies read more
February 3, 2025 The Brain-Heart Axis: Exploring the Hidden Link Between Cardiovascular and Neurological Health read more